Skip to main content
Clinical Trials/TCTR20240601001
TCTR20240601001RecruitingPhase 1

Assessment of the Efficacy and Safety of On-Demand Use of Tadalafil Alone versus Combination with Lidocaine Spray for the Treatment of Patients with Erectile Dysfunction and Premature Ejaculation

The First Affiliated Hospital of Gannan Medical University0 sites118 target enrollmentStarted: June 1, 2024Last updated:
Conditions

Trial Snapshot

Phase
Phase 1
Status
Recruiting
Sponsor
Enrollment
118

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 Years to 60 Years (—)
Sex
Male

Inclusion Criteria

  • Couples who have had regular sexual activity within the past six months.
  • Patients with a detailed medical history (including sexual history) and a comprehensive physical examination.
  • Eligible patients underwent a four-week screening diagnostic period, recording the number of sexual activities, intra-vaginal ejaculation latency period, sexual performance, and satisfaction, etc.
  • Exclusions were made for heart failure, chronic prostatitis/chronic pelvic pain syndrome, paraplegia, depression, etc.

Exclusion Criteria

  • Heart failure
  • Chronic prostatitis/prostatodynia

Investigators

Sponsor
The First Affiliated Hospital of Gannan Medical University

Similar Trials

Assessment of the Efficacy and Safety of... | Clinical Trial